Stock CORV CORREVIO PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Correvio Pharma Corp. Nasdaq

Equities

CORV

CA22026V1058

Delayed Nasdaq
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Correvio Pharma Corp. +1.06% +2.41%
2020 Mark Corrigan Departs as CEO from Correvio Pharma Corp CI
2020 Justin Renz, CFO Departs from Correvio Pharma Corp CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CORV Stock
  4. CORV Stock
  5. News Correvio Pharma Corp.
  6. MarketScreener Editorial Features